Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC-ND 4.0Kidney International Reports

Cytomegalovirus: Updated Approach to Management for Kidney Transplant Recipients

  • Sahrish Ilyas1
  • Emily A. Blumberg1
  1. 1Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Read full textPDFDOICite

Abstract

Cytomegalovirus (CMV) is the most common opportunistic infection after kidney transplantation. A cause of symptomatic infection, it has also been associated with an increased risk of other infections, rejection, allograft loss, and mortality. Recent advances in diagnosis, prevention, and treatment have improved the management of this infection. This article reviews updated therapeutic and diagnostic approaches, highlighting the recommendations of the International CMV Consensus Conference and noting those areas in which further research is needed.

Related

  1. Virologic and Exploratory Immunologic Characterization of Relapsing Human Cytomegalovirus (HCMV) DNAemia in Solid Organ Transplant Recipients: A Prospective Observational Cohort Study
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    S. Servais, N. Dumontier, L. Biard +12
    Clinical Microbiology and InfectionPeer-reviewedLicence not statedFull text25 citedEpidemiology & public healthHAL
  3. Immunosuppressive therapy management during sepsis in kidney transplant recipients: a prospective multicenter study
    Valentin Rivet, Adrien Joseph, Romain Arrestier +10
    Annals of Intensive CarePeer-reviewedCC BY5 citedSurgery & anaesthesiaHAL
  4. Maribavir in lung transplant recipients with cytomegalovirus infection: real-life experience
    Tobias Veit, Stefan Trost, Teresa Kauke +9
    InfectionPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  5. Association of eplet mismatch load and allograft injury in kidney transplant recipients
    Clinical kidney journalPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{ilyas2026cytomegalovirus,
  title = {{Cytomegalovirus: Updated Approach to Management for Kidney Transplant Recipients}},
  author = {Sahrish Ilyas and Emily A. Blumberg},
  journal = {Kidney International Reports},
  year = {2026},
  month = sep,
  doi = {10.1016/j.ekir.2026.107088},
  url = {https://doi.org/10.1016/j.ekir.2026.107088},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Cytomegalovirus: Updated Approach to Management for Kidney Transplant Recipients
AU  - Sahrish Ilyas
AU  - Emily A. Blumberg
PY  - 2026
DA  - 2026/09/21
JO  - Kidney International Reports
DO  - 10.1016/j.ekir.2026.107088
UR  - https://doi.org/10.1016/j.ekir.2026.107088
AB  - Cytomegalovirus (CMV) is the most common opportunistic infection after kidney transplantation. A cause of symptomatic infection, it has also been associated with an increased risk of other infections, rejection, allograft loss, and mortality. Recent advances in diagnosis, prevention, and treatment have improved the management of this infection. This article reviews updated therapeutic and diagnostic approaches, highlighting the recommendations of the International CMV Consensus Conference and noting those areas in which further research is needed.
SN  - 2468-0249
ER  -